Generics 19

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dapsone manufacturers

19 products found

Filters

19 products found

dapsone

Tablets 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , United Kingdom , Vietnam
Available for
Distribution only
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

dapsone

Tablets 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply
Manufacturer #15941
A pharmaceutical leader that deals with solid, semi-solid, and liquid dosage forms of medicine. This company is involved in manufacturing of its own as well as marketing and distribution of products manufactured by other companies as well.

Manufacturer usually replies in 24 days

dapsone

Tablets 25 mg, 100 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18870

Manufacturer usually replies in 9 days

dapsone

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17782
Over 40 years ago, it was founded in North America. The company has long been a leader in the generic product manufacturing industry. It has earned a name for itself in the production of branded and over-the-counter private label items. Customers are actively and attentively listened to by the company. They anticipate the evolution of new markets and are ready to adapt to new medical needs.

Manufacturer usually replies in 8 days

dapsone

Tablets 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 8 days

dapsone

Cutaneous gel 5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19152

Manufacturer usually replies in 2 days

dapsone

Cutaneous gel 5%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17902
The commitment of the company for more than 25 years has been to improve ourselves day by day to provide medicines that allow everyone to enjoy a better quality of life. Production based on international standards and an industrial complex equipped with the highest technology ensure the quality of the medicines.

Manufacturer usually replies in 3 days

dapsone

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17558

Manufacturer usually replies in 5 days

dapsone

Tablets 100 mg

Dossier type
ACTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
India
Manufacturer #18530

Manufacturer usually replies in 4 days

dapsone

Injection 20 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

dapsone

Tablets 25 mg, 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

dapsone

Cutaneous gel 7.5%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17885
The company was established in the initial of 1930s. The company’s mission is to develop and elaborate medicinal specialties of high quality and efficacy to offer trustworthy therapeutic alternatives to health professionals; in short, to offer the national and international medical community, medicines of excellence and quality

Manufacturer usually replies in 10 days

dapsone

Tablets 100mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
Manufacturer #1447
The company was established in the early 1990s. It is one of the largest integrated pharmaceutical groups with a firm focus on protecting the nation via providing accessible and affordable healthcare solutions, with operations in Malaysia and Indonesia. It is involved in various segments of the pharmaceutical value chain, including research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales and marketing, as well as a community pharmacy.

Manufacturer usually replies in 6 days

dapsone

Tablets 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Unavailable markets
United Kingdom
Manufacturer #32970

Manufacturer usually replies in 9 days

dapsone

Tablets 50 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #19316

Manufacturer usually replies in 20 days

dapsone

Tablets 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19729

Manufacturer usually replies in 12 days

dapsone

Cutaneous gel 5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #7170
A pharmaceutical manufacturer based in Europe that has been active in 20+ countries selling its products in Europe, CIS, Middle East, Africa, and LATAM for 60+ years. The main therapeutic areas include cardiology, CNS, and rare diseases. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 7 days

dapsone

Gel 7.5 % - 30 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Comments
Reference Product : Aczone
Manufacturer #2748
It is a privately held pharmaceutical company based in southeast Europe that was established in the 1990s to import and introduce pharmaceutical items into medicine. The company began by importing hemophilia and intensive care supplies, as well as immunoglobulin-containing items. To suit market demands, the company has added additional dermatological, cardiological, urological, and surgical goods to its portfolio since then. They now offer a diverse product line that includes not only prescription but also OTC, medical gadgets, and dermo-cosmetics.

Manufacturer usually replies in 7 days

pyrimethamine + dapsone

Tablets 12.5 mg + 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Singapore
GMP approvals
PICS
Manufacturer #20928
It is celebrating over 50 years of continued success. It is one of the largest manufacturers of generic pharmaceuticals and provides a comprehensive suite of fully integrated "one-stop" contract manufacturing solutions. It owns and operates in more than one PIC/S GMP-certified manufacturing facility.

Manufacturer usually replies in 23 days

Dapsone Manufacturers Dapsone is a synthetic derivative of diamino-sulfone with anti-inflammatory and anti-bacterial properties. Dapsone belongs to a class of drugs known as sulfones. Dapsone is a sulfonamide related drug used for the therapy of leprosy and dermatitis herpetiformis. Dapsone is the principal drug in multidrug regimen recommended by the World Health Organization for the treatment of leprosy. As an anti - infective agent, it is also used for treating malaria and recently for Pneumocystis carinii pneumonia in AIDS patients. This medication along with other drugs also used to treat Hansen’s disease. Dapsone is advised as a prescription product as well as generic prescription product. Dapsone is marketed by manufacturers under the Brand name of Aczone, Avlosulfon. It is issued on prescription only. This medication is available in the dosage form of Gel and Tablet. The Gel form is available in a dosage strength of 50 mg / 1g and 75 mg / 1g while tablets are available in 25 mg and 100 mg. Gel is applied topically and tablets are for oral use which can be taken with or without food, usually once daily or as directed by a physician. For Dermatitis Herpetiformis, the dosage should be individually titrated starting in adults with 50mg daily and correspondingly smaller doses in children, if control over the treatment is not achieved within the range of 50 - 300 mg daily, higher doses may be tried but the dosage should be reduced to a minimum maintenance level as soon as possible. The recommended dose of Dapsone in patients with leprosy and borderline leprosy is 100 mg daily with the co-administration of other drugs. Dapsone gel 7.5 % is available in the US and Australia for the topical treatment of acne. The gel is applied once daily. The recommended storage conditions for Dapsone is to store at 20° C - 25° C (68° F - 77° F) away from light, moisture and heat and Protect from freezing. Wholesale Price of Dapsone The wholesale price of Dapsone oral tablet 25 mg is around $ 51 for a supply of 30 tablets with a per unit cost of $ 1.70 depending up on the pharmacy, the lowest available per unit cost is $ 1.64 for a set of 100 tablets. The per unit price of Dapsone 100 mg oral tablet is $ 1.98 and for a set of 100 tablets it costs around $ 198. The 5 % Dapsone Gel per unit costs around $ 5.52. Dapsone - Mechanism of Action Dapsone is a competitive inhibitor of para-amino benzoic acid (PABA), a critical substrate for folate biosynthesis. Dapsone blocks the condensation of PABA and 7,8-dihydro-6-hydroxymethylpterin-pyrophosphate from forming 7,8-dihydrofolic acid. The key enzyme in this step is the dihydropteroate synthase (DHPS). Dapsone competitively inhibits this consideration and ultimately results in the decreased production of tetrahydrofolate, an essential component of nucleic acid biosynthesis in Mycobacterium leprae. Thus, Dapsone acts against bacteria and protozoa by inhibiting the synthesis of dihydrofolic acid through competition with para-amino benzoate for the active site of dihydropteroate synthase. Finding Dapsone Manufacturers and Suppliers To find a trustworthy partner in our business is one of the biggest challenges and to defeat that and to make one’s work / life easy in finding the reliable manufacturer and supplier of Dapsone one can visit the Pipelinepharma website which helps buyers in finding the dependable manufacturers and suppliers of Dapsone. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects proprietor with the consumers for the business development. The buyer can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier and its status, regulatory filings, approvals, and more.